This inventor holds 35 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Nippon Shinyaku Company, Ltd., Mitsubishi Chemical Industries Limited, Takara Shuzo Co., Inc.. Active years: 1977-1988.
Location History:
- Minami Kyoto, JA (1977)
- Kyoto, JA (1977 - 1978)
- Kameoka, JP (1978)
- Nagaokakao, JP (1982)
- Nagaokakyo, JP (1980 - 1987)
- Nagoakakyo, JP (1985 - 1987)
- Magaokakyo, JP (1987)
- Kyoto, JP (1979 - 1988)
Company Filing History:
33 out of 229Â 
2 out of 614Â 
1 out of 190Â Years Active: 1977-1988
Areas of Expertise:
Title: Hiroshi Enomoto: A Leading Innovator in Immunomodulation and Anti-Inflammatory Research
Introduction
Hiroshi Enomoto is an accomplished inventor based in Nagaokakyo, Japan, with an impressive portfolio of 35 patents. His work predominantly focuses on the development of pharmaceutical compounds that exhibit significant immunomodulating and anti-inflammatory properties.
Latest Patents
Among his latest innovations are the immunomodulating agents derived from phenylacetic acid and various 4-quinolone derivatives. The phenylacetic acid derivatives, as outlined in his patent, possess immunomodulating activity, making them valuable in treating a range of health conditions. In addition, his work on 4-quinolone derivatives highlights their utility in anti-inflammatory, anti-allergenic, antitussive, expectorant, and antithrombotic applications, alongside descriptions of pharmaceutical compositions that utilize these compounds.
Career Highlights
Hiroshi Enomoto has made significant contributions through his tenure at esteemed companies such as Nippon Shinyaku Company, Ltd. and Mitsubishi Chemical Industries Limited. His work at these organizations has allowed him to further his research and patent filings, establishing him as a prominent figure in the pharmaceutical industry.
Collaborations
Throughout his career, Hiroshi has collaborated with notable colleagues, including Yoshiaki Aoyagi and Yoshiaki Yoshikuni. These partnerships have been instrumental in fostering innovative research and enhancing the impact of their collective work on drug development.
Conclusion
Hiroshi Enomoto's dedication to innovation in the field of pharmaceuticals is reflected in his substantial patent portfolio and his ongoing research efforts. His contributions in immunomodulation and anti-inflammatory therapies continue to shape the landscape of modern medicine, underscoring the importance of innovation in the healthcare sector.